P.Y. Scarabin

The 4G/5G Genetic Polymorphism in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene Is Associated with Differences in Plasma PAI-1 Activity but not with Risk of Myocardial Infarction in the ECTIM Study

Shu Ye, FR Green, P.Y. Scarabin et al. · Thrombosis and Haemostasis · 1995 · 236 citations

Heart Failure, Genetics, Genetic Epidemiology +16

Immunoreactivity of Tissue Plasminogen Activator and of Its Inhibitor Complexes

Mats Rånby, Giang Huong Nguyen, P.Y. Scarabin et al. · Thrombosis and Haemostasis · 1989 · 89 citations

Association between TAFI antigen and Ala l47Thr polymorphism of the TAFI gene and the angina pectoris incidence

Pierre‐Emmanuel Morange, I. Juhan Vague, P.Y. Scarabin et al. · Thrombosis and Haemostasis · 2003 · 54 citations

Tafi Gene, Genetics, Genetic Epidemiology +5

Effects of long term administration of ticlopidine on platelet function and hemostatic variables

J. Conard, C Lecrubier, P.Y. Scarabin et al. · Thrombosis Research · 1980 · 51 citations

Thrombopoiesis, Thrombosis, Cardiovascular Disease +12

Platelet Aggregation Related to Age in Diabetes Mellitus

C Lecrubier, P.Y. Scarabin, F. Grauso et al. · Pathophysiology of Haemostasis and Thrombosis · 1980 · 15 citations